Michael Panzara
Director/Board Member at ATHIRA PHARMA, INC.
Net worth: - $ as of 2024-03-30
Profile
Michael Panzara is an Independent Director at Athira Pharma, Inc. and the Chief Medical Officer at Neurvati Neurosciences, Inc. He was previously a Director at Wave Life Sciences UK Ltd.
from 2016 to 2022, the Chief Medical Officer-Neurology & Vice President at Biogen, Inc. from 2001 to 2009, and the Head-Multiple Sclerosis & Neurology at Genzyme Corp.
from 2009 to 2016.
He also served as the Chief Medical Officer & Head-Therapeutics at Wave Life Sciences Ltd.
from 2020 to 2022.
Panzara received his undergraduate degree from the University of Pennsylvania, his graduate degree from Harvard T.H.
Chan School of Public Health, and another undergraduate degree from Stanford University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ATHIRA PHARMA, INC.
-.--% | 2023-05-18 | 0 ( -.--% ) | - $ | 2024-03-30 |
Michael Panzara active positions
| Companies | Position | Start |
|---|---|---|
| ATHIRA PHARMA, INC. | Director/Board Member | 2022-03-17 |
| Neurvati Neurosciences, Inc. | Chief Tech/Sci/R&D Officer | 2022-09-30 |
Former positions of Michael Panzara
| Companies | Position | End |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Chief Tech/Sci/R&D Officer | 2022-10-13 |
Wave Life Sciences UK Ltd.
 Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Wave Life Sciences Ltd., Wave Life Sciences UK Ltd. is a pharmaceutical company founded in 2017. The private company is based in Birmingham, UK and specializes in manufacturing pharmaceutical products. | Director/Board Member | 2021-12-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2016-06-30 |
| BIOGEN INC. | Corporate Officer/Principal | 2009-08-31 |
Training of Michael Panzara
| University of Pennsylvania | Undergraduate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
| Stanford University School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| Private companies | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Wave Life Sciences UK Ltd.
Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Wave Life Sciences Ltd., Wave Life Sciences UK Ltd. is a pharmaceutical company founded in 2017. The private company is based in Birmingham, UK and specializes in manufacturing pharmaceutical products. | Health Technology |
| Neurvati Neurosciences, Inc. |
- Stock Market
- Insiders
- Michael Panzara
